Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic, Brand Industry Codes Of Ethics Share Common Themes, Language

Executive Summary

Association for Accessible Medicines code of business ethics shares many of the same phrases as the Pharmaceutical Research and Manufacturers of America's Code of Interactions with Healthcare Professionals.

You may also be interested in...



GPhRMA? Generic Trade Group Picks Up Another Exec From Brand Association

PhRMA Senior Counsel Jeffrey Francer will become GPhA's General Counsel in mid-November.

Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing

“Expedited Agency Review” idea would require an FDA review of proposed safety-related labeling changes before they are made and end the CBE-0 system brand companies already use and generics could be required to adopt.

US FDA Holds First Hybrid Meeting With Industry

A Type A meeting was held in-person with a virtual contingent, the FDA clarified to the Pink Sheet. Several other meeting requests received were eligible, but did not seek an in-person session.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB002259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel